Drug
Filgrastim SD 01
Filgrastim SD 01: highest development phase Phase 2, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Filgrastim-SD/01 NCT00050674 | Phase 2 | Non-small Cell Lung Cancer |
Latest
No recent events.
Follow Filgrastim SD 01 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.